Third Harmonic Bio, Inc.
THRDDelisted Jul 31, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001923840
Third Harmonic Bio, Inc. was delisted on Jul 31, 2025; its insiders filed their last Form 4 on Aug 14, 2025; 107 institutions reported holding it in 13F filings for Q2 2025, worth $210.2M in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Third Harmonic Bio, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 56
- +8 vs. Q2 2023
- Shares held
- 37.8M
- +1.73M (+4.8%) vs. Q2 2023
- Total value
- $241.5M
- +$68.0M (+39.2%) vs. Q2 2023
- New holders
- 11
- 18 more added
- Sold out
- 3
- 11 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting THRD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 4 | $110.0K |
| Q1 2026 | 4 | $110.0K |
| Q4 2025 | 4 | $111.5K |
| Q3 2025 | 18 | $1.19M |
| Q2 2025 | 107 | $210.2M |
| Q1 2025 | 100 | $134.4M |
| Q4 2024 | 98 | $462.5M |
| Q3 2024 | 85 | $596.6M |
| Q2 2024 | 77 | $523.2M |
| Q1 2024 | 71 | $357.6M |
| Q4 2023 | 62 | $416.0M |
| Q3 2023 | 56 | $241.5M |
| Q2 2023 | 48 | $173.5M |
| Q1 2023 | 49 | $149.7M |
| Q4 2022 | 50 | $153.1M |
| Q3 2022 | 40 | $672.8M |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Third Harmonic Bio, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 10,907,859 | $69.7M | 10.80% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 5,779,071 | $36.9M | 0.85% | 00.0% | Unchanged |
| BVF Inc | 4,365,933 | $27.9M | 0.75% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 2,982,444 | $19.1M | 0.65% | +893,664+42.8% | Added |
| General Atlantic LLC | 2,958,762 | $18.9M | 0.29% | 00.0% | Unchanged |
| Tang Capital Management LLC | 1,800,000 | $11.5M | 1.62% | 00.0% | Unchanged |
| Commodore Capital LP | 1,700,000 | $10.9M | 1.27% | +706,706+71.1% | Added |
| Braidwell LP | 1,653,991 | $10.6M | 0.33% | +1,653,991 | New |
| BlackRock Inc. | 1,157,119 | $7.39M | 0.00% | +82,549+7.7% | Added |
| Ra Capital Management, L.P. | 961,863 | $6.15M | 0.12% | +961,863 | New |
| Vanguard Group Inc | 773,458 | $4.94M | 0.00% | +3,615+0.5% | Added |
| Boxer Capital, LLC | 520,417 | $3.33M | 0.18% | −50,000−8.8% | Reduced |
| Geode Capital Management, LLC | 361,155 | $2.31M | 0.00% | +44,480+14.0% | Added |
| DAFNA Capital Management LLC | 300,000 | $1.92M | 0.60% | +300,000 | New |
| State Street Corp | 278,133 | $1.78M | 0.00% | +13,430+5.1% | Added |
| Atika Capital Management LLC | 203,199 | $1.30M | 0.18% | +203,199 | New |
| Adage Capital Partners GP, L.L.C. | 192,027 | $1.23M | 0.00% | +192,027 | New |
| Northern Trust Corp | 154,110 | $984.8K | 0.00% | +9,238+6.4% | Added |
| Charles Schwab Investment Management Inc | 126,855 | $810.6K | 0.00% | +23,585+22.8% | Added |
| UBS Oconnor LLC | 125,000 | $798.8K | 0.01% | +125,000 | New |
| Morgan Stanley | 106,525 | $680.7K | 0.00% | −26,593−20.0% | Reduced |
| Bridgeway Capital Management, LLC | 89,100 | $569.3K | 0.01% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 57,550 | $367.7K | 0.00% | +4,197+7.9% | Added |
| Jacobs Levy Equity Management, Inc | 33,428 | $213.6K | 0.00% | +33,428 | New |
| Nuveen Asset Management, LLC | 26,824 | $171.4K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 19,553 | $124.9K | 0.00% | −799−3.9% | Reduced |
| Rhumbline Advisers | 18,628 | $119.0K | 0.00% | +1,841+11.0% | Added |
| Prelude Capital Management, LLC | 16,397 | $104.8K | 0.01% | +555+3.5% | Added |
| Deutsche Bank AG | 14,527 | $92.8K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 12,960 | $82.8K | 0.00% | −2,564−16.5% | Reduced |
| MetLife Investment Management | 11,604 | $74.2K | 0.00% | +11,604 | New |
| UBS Group AG | 10,646 | $68.0K | 0.00% | −613−5.4% | Reduced |
| CIBC Asset Management Inc | 10,573 | $67.6K | 0.00% | 00.0% | Unchanged |
| American International Group, Inc. | 9,722 | $62.1K | 0.00% | +346+3.7% | Added |
| Allspring Global Investments Holdings, LLC | 7,309 | $46.7K | 0.00% | +6,977+2,101.5% | Added |
| New York State Common Retirement Fund | 5,018 | $32.1K | 0.00% | −9,396−65.2% | Reduced |
| Annapolis Financial Services, LLC | 5,000 | $31.9K | 0.01% | +5,000 | New |
| Wells Fargo & Company | 4,793 | $30.6K | 0.00% | −2,570−34.9% | Reduced |
| California State Teachers Retirement System | 4,298 | $27.5K | 0.00% | −2,182−33.7% | Reduced |
| Royal Bank of Canada | 3,627 | $23.0K | 0.00% | +1,501+70.6% | Added |
| Barclays PLC | 3,510 | $22.4K | 0.00% | −450−11.4% | Reduced |
| FMR LLC | 3,445 | $22.0K | 0.00% | +693+25.2% | Added |
| The PNC Financial Services Group, Inc. | 2,981 | $19.0K | 0.00% | +2,441+452.0% | Added |
| STRS Ohio | 2,900 | $18.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,140 | $13.7K | 0.00% | −3,472−61.9% | Reduced |
| Amalgamated Bank | 2,037 | $13.0K | 0.00% | +1,313+181.4% | Added |
| Legal & General Group Plc | 1,816 | $11.6K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 1,255 | $8.02K | 0.00% | +1,255 | New |
| Ameritas Investment Partners, Inc. | 1,010 | $6.45K | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 320 | $2.04K | 0.00% | +320 | New |
| Covestor Ltd | 207 | $1.00K | 0.00% | 00.0% | Unchanged |
| Glassman Wealth Services | 149 | $952 | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 137 | $875 | 0.00% | +100+270.3% | Added |
| Toronto Dominion Bank | 31 | $198 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 9 | $58 | 0.00% | −5,792−99.8% | Reduced |
| CWM, LLC | 44 | $0 | 0.00% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −2,793,149−100.0% | Sold out |
| Bain Capital Life Sciences Investors, LLC | 0 | $0 | 0.00% | −640,631−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −16,460−100.0% | Sold out |